TC
HITK

TFS Capital’s HI-TECH PHARMACAL INC HITK Stock Holding History

TFS Capital’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-19,199
Closed -$833K – 1840
2013
Q4 		$833K Sell
19,199
-74,270
-79% -$3.21M 0.04% 628
2013
Q3 		$4.03M Buy
+93,469
New +$3.58M 0.18% 138

Other funds holding HITK

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TFS Capital's HITK Position: Q1 2014 in Review

TFS Capital sold out of HI-TECH PHARMACAL INC (HITK) in Q1 2014, closing a stake of 19,199 shares — an estimated $833K sold.

TFS Capital first reported a position in HITK in Q3 2013 and held it in 2 quarters. The position peaked at $4.03M in Q3 2013. 108 funds tracked by Wall St. Rank hold HITK as of Q1 2014.

  • TFS Capital reported no remaining HI-TECH PHARMACAL INC position as of Q1 2014 after selling out during the quarter.
  • TFS Capital sold 19,199 HI-TECH PHARMACAL INC shares in Q1 2014, an estimated $833K.
  • TFS Capital first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 2 quarters.
  • TFS Capital's HI-TECH PHARMACAL INC position peaked at $4.03M in Q3 2013.
  • 108 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q1 2014.

Based on TFS Capital's 13F filing for Q1 2014, filed 5 May 2014.